Cited by 2,582Heart Failure Treatment and ManagementCardiac Fibrosis and RemodelingNutrition and Health in Aging

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure

Open access

Levine, Beth, Kalman, Jill, Mayer, Lloyd, Fillit, Howard M., Packer, Milton·1990·New England Journal of Medicine

DOI 10.1056/nejm199007263230405

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND AND METHODS: Although cachexia often accompanies advanced heart failure, little is known about the causes of the cachectic state. To assess the potential role of tumor necrosis factor in the pathogenesis of cardiac cachexia, we measured serum levels of the factor in 33 patients with chronic heart failure, 33 age-matched healthy controls, and 9 patients with chronic renal failure. RESULTS: Mean (+/- SEM) serum levels of tumor necrosis factor were higher in the patients with heart failure (115 +/- 25 U per milliliter) than in the healthy controls (9 +/- 3 U per milliliter; P less than 0.001). Nineteen of the patients with chronic heart failure had serum levels of tumor necrosis factor greater than or equal to 39 U per milliliter (greater than 2 SD above the mean value for the control group), whereas the remaining 14 patients had serum levels of tumor necrosis factor below this level. The patients with high levels of tumor necrosis factor were more cachectic than those with low levels (82 +/- 3 vs. 95 +/- 6 percent of ideal body weight, respectively; P less than 0.05) and had more advanced heart failure, as evidenced by their higher values for plasma renin activity (2.92 +/- 0.53 vs. 1.06 +/- 0.53 ng per liter per second [10.5 +/- 1.9 vs. 3.8 +/- 1.9 ng per milliliter per hour]; P less than 0.01) and lower serum sodium concentration (135 +/- 1 vs. 138 +/- 1 mmol per liter; P less than 0.05). The group with high levels of tumor necrosis factor also had lower hemoglobin levels (7.82 +/- 0.2 vs. 8.69 +/- 0.4 mmol per liter [12.6 +/- 0.4 vs. 14.0 +/- 0.6 g per deciliter]) and higher values for blood urea nitrogen (19.5 +/- 2.2 vs. 12.5 +/- 1.8 mmol per liter) than the group with low levels of tumor necrosis factor (P less than 0.05 for both). The high levels of tumor necrosis factor were not due solely to decreased renal clearance, however, since the levels in the patients with heart failure were considerably higher than those in the nine patients with chronic renal failure (115 +/- 25 vs. 45 +/- 25 U per milliliter; P less than 0.05). CONCLUSIONS: These findings indicate that circulating levels of tumor necrosis factor are increased in cachectic patients with chronic heart failure and that this elevation is associated with the marked activation of the renin-angiotensin system seen in patients with end-stage cardiac disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199007263230405

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for Activity
Gillis, S. A., Ferm, M. M., Ou, W., & Smith, K. A. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.120.6.2027 · Cited by 3,273
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.
Le, J., & Vilček, J. (1987) · PubMed · Cited by 1,327
Diseases of the heart
Friedberg, C. K. (1966) · Biblioteca Digital (Real Academia Nacional de Medicina) · Cited by 1,308
ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE
Waage, A., Halstensen, A. I., & Espevik, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91728-4 · Cited by 1,085
Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.
Beutler, B., Milsark, I. W., & Cerami, A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.3972 · Cited by 771
Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious Purpura
Girardin, E. P., Grau, G. E., Dayer, J., Roux-Lombard, P., the J5 Study Group*, & Lambert, P.-H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808183190703 · Cited by 737
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
Tracey, K. J., He, W., Manogue, K. R., Fong, Y., HESSE, D. G., Nguyen, H. T., Kuo, G. C., Beutler, B., Cotran, R. S., & Cerami, A. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.3.1211 · Cited by 730
Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome
Lähdevirta, J., Maury, C. P. J., Teppo, A., & Repo, H. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90576-1 · Cited by 717

Show all 55 references

Research works printed but not linked: 4

Packer, 1987, Circulation, 75, IV-80
Bertani, 1989, Am J Pathol, 134, 419
Pessina, 1987, Lymphokine Res, 6, 35
Le, 1987, Lab Invest, 56, 234

Sorted by citations

Items 301–400 of 1,003

Hypothalamic mechanisms in cachexia
Grossberg, A. J., Scarlett, J. M., & Marks, D. L. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.03.011 · Cited by 162
“Indeed, elevated circulating levels of TNF-α and IL-6 in patients with cardiac cachexia are the strongest predictor for pathological weight loss [27,28].”
Anti–Tumor Necrosis Factor-Alpha Improves Myocardial Recovery After Ischemia and Reperfusion
Gurevitch, J., Frolkis, I., Yuhas, Y., Lifschitz‐Mercer, B., Berger, E., Paz, Y., Matsa, M., Kramer, A., & Mohr, R. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00328-8 · Cited by 154
Catabolism in chronic heart failure
Berry, C. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1882 · Cited by 159
“first described elevated levels of TNF in severe chronic heart failure([41]).”
Background
Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure
Tsutamoto, T., 久永, 智., 深井, 大., Wada, A., Maeda, Y., Maeda, K., & Kinoshita, M. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80231-8 · Cited by 160
The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure
Yu, L., & Feng, Z. (2018) · Mediators of Inflammation · doi:10.1155/2018/9874109 · Cited by 169
“, who reported elevated levels of tumor necrosis factor α (TNFα) in patients with HF with reduced ejection fraction [8].”
Background
p38 MAP Kinase Mediates Inflammatory Cytokine Induction in Cardiomyocytes and Extracellular Matrix Remodeling in Heart
Li, M., Georgakopoulos, D., Lü, G., Hester, L., Kass, D. A., Hasday, J. D., & Wang, Y. (2005) · Circulation · doi:10.1161/01.cir.0000165117.71483.0c · Cited by 158
Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells
Li, Y. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00297-1 · Cited by 156
Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide
McEntegart, M. B., Awèdé, B., Petrie, M. C., Sattar, N. A., Dunn, F. G., MacFarlane, N. G., & McMurray, J. J. V. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm033 · Cited by 157
Evidence for altered interleukin (IL)‐18 pathway in human heart failure
Mallat, Z., Heymes, C., Corbaz, A., Logeart, D., Alouani, S., Solal, A. C., Seidler, T., Hasenfuss, G. P., Chvatchko, Y., Shah, A. M., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-2426fje · Cited by 160
Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets
Reina‐Couto, M., Pereira‐Terra, P., Quelhas‐Santos, J., Silva-Pereira, C., Albino‐Teixeira, A., & Sousa, T. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.746494 · Cited by 164
Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice
Kubota, T., McTiernan, C. F., Frye, C. S., Demetris, A. J., & Feldman, A. M. (1997) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(97)90045-2 · Cited by 157
Plasma Fas Ligand, an Inducer of Apoptosis, and Plasma Soluble Fas, an Inhibitor of Apoptosis, in Patients With Chronic Congestive Heart Failure
Nishigaki, K., Minatoguchi, S., Seishima, M., Asano, K., Noda, T., Yasuda, N., Sano, H., Kumada, H., Takemura, M., Noma, A., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00055-7 · Cited by 155
The central role of hypothalamic inflammation in the acute illness response and cachexia
Burfeind, K. G., Michaelis, K. A., & Marks, D. L. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.10.038 · Cited by 156
“Furthermore, elevated circulating levels of TNFα and IL-6 in cardiac cachexia are the strongest predictor for pathological weight loss [75,76].”
Background
Molecular mechanism of sarcopenia and cachexia: recent research advances
Sakuma, K., Aoi, W., & Yamaguchi, A. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1933-3 · Cited by 160
Cytokines, apoptosis and cachexia: the potential for TNF antagonism.
Sharma, R., & Anker, S. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00244-9 · Cited by 156
N-Terminal Pro-Brain Natriuretic Peptide
Wang, A. Y.-M., Lam, C. W.-K., Yu, C., Wang, M., Chan, I. H.-S., Zhang, Y., Lui, S., & Sanderson, J. E. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121299 · Cited by 156
“somewhat contrary to our belief that volume overload is a process that involves immune activation (55).”
Background
Dissociation between plasma and monocyte‐associated cytokines during sepsis
Muñoz, C., Misset, B., Fitting, C., Blériot, J. P., Jean‐Carlet, & Cavaillon, J. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210928 · Cited by 156
Tumor necrosis factor-α alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes
Lee, S.-H., Chen, Y., Chen, Y.-J., Chang, S., TAI, C., Wongcharoen, W., Yeh, H., Lin, C., & Chen, S.-A. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.02.029 · Cited by 155
“In patients with heart failure, TNFα in the circulation is elevated and their serum concentration is correlated with the disease severity (Levine et al., 1990; Latini et al., 1994).”
Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure.
Matsumori, A., Shioi, T., Yamada, T., Matsui, S., & Sasayama, S. (1994) · Circulation · doi:10.1161/01.cir.89.3.955 · Cited by 155
CXC-chemokines, a new group of cytokines in congestive heart failure — possible role of platelets and monocytes
Damås, J. K. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00262-x · Cited by 153
Decreased Activity of the l -Arginine–Nitric Oxide Metabolic Pathway in Patients With Congestive Heart Failure
Katz, S. D., Khan, T., Zeballos, G. A., Mathew, L., Potharlanka, P., Knecht, M., & Whelan, J. (1999) · Circulation · doi:10.1161/01.cir.99.16.2113 · Cited by 153
Serial circulating concentrations of c‐reactive protein, interleukin (il)‐4, and il‐6 in patients with acute left heart decompensation
Sato, Y., Takatsu, Y., Kataoka, K., Yamada, T., Taniguchi, R., Sasayama, S., & Matsumori, A. (1999) · Clinical Cardiology · doi:10.1002/clc.4960221211 · Cited by 152
Experimental and Clinical Basis for the Use of Statins in Patients With Ischemic and Nonischemic Cardiomyopathy
Ramasubbu, K., Estep, J. D., White, D. L., Deswal, A. M., & Mann, D. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.009 · Cited by 151
Tumor necrosis factor-α decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes*
Kao, Y., Chen, Y., Cheng, C., Lee, T.-I., Chen, Y., & Chen, S.-A. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b4a854 · Cited by 151
“TNF- has been found to be elevated in patients with congestive heart failure and correlated with the severity of heart failure (4).”
Background
Serum albumin concentration and heart failure risk
Gopal, D. M., Kalogeropoulos, A. P., Georgiopoulou, V. V., Tang, W. H. W., Methvin, A. B., Smith, A. L., Bauer, D. C., Newman, A. B., Kim, L., Harris, T. B., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.05.022 · Cited by 150
Mechanisms and Clinical Consequences of Untreated Central Sleep Apnea in Heart Failure
Costanzo, M. R., Khayat, R., Ponikowski, P. P., Augostini, R. S., Stellbrink, C., Mianulli, M. J., & Abraham, W. T. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.10.025 · Cited by 153
“Inflammation also has been shown to contribute to pulmonary edema as well as to the anorexia and cachexia frequently occurring in patients with advanced HF (75,78).”
Background
Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M
Abe, H., Takeda, N., Isagawa, T., Semba, H., Nishimura, S., Morioka, M. S., Nakagama, Y., Sato, T., Soma, K., Koyama, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10859-w · Cited by 152
Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease
Sharma, R., Bolger, A. P., Li, W., Davlouros, P. A., Volk, H., Poole-Wilson, P. A., Coats, A. J. S., Gatzoulis, M. Α., & Anker, S. D. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00536-8 · Cited by 149
Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
Spieker, L. E., Noll, G., Ruschitzka, F. T., & Lüscher, T. F. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01210-4 · Cited by 150
“immunologic activation, which occurs in CHF (183,184),”
The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model
Date, M., Morita, T., Yamashita, N., Nishida, K., Yamaguchi, O., Higuchi, Y., Hirotani, S., Matsumura, Y., Hori, M., Tada, M., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01826-5 · Cited by 147
“Cardiac hypertrophy and heart failure are frequently accompanied by elevated plasma levels of TNF- (19,20).”
Background
Tumor Necrosis Factor Antagonism With Etanercept Improves Systemic Endothelial Vasoreactivity in Patients With Advanced Heart Failure
Fichtlscherer, S., Rössig, L., Breuer, S., Vasa‐Nicotera, M., Dimmeler, S., & Zeiher, A. M. (2001) · Circulation · doi:10.1161/hc5001.101749 · Cited by 147
Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients
Ferreira, R. C., Ianni, B. M., Abel, L. C. J., Buck, P., Mady, C., Kalil, J. E., & Cunha‐Neto, E. (2003) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762003000300021 · Cited by 147
“E-mail: edecunha@usp.br Receved 18 September 2002 Accepted 23 January 2003 Increased circulating levels of TNF-α were observed in heart failure patients from diverse aetiologies (Levine et al. 1990, Ferrari et al. 1995, Torre-Amione et al. 1996).”
Background
Aldose Reductase Mediates the Lipopolysaccharide-induced Release of Inflammatory Mediators in RAW264.7 Murine Macrophages
Ramana, K. V., Fadl, A. A., Tammali, R., Reddy, A. B. M., Chopra, A. K., & Sk, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603819200 · Cited by 145
Nutritional Status is Associated with Inflammation and Predicts a Poor Outcome in Patients with Chronic Heart Failure
Nakagomi, A., Kohashi, K., Morisawa, T., Kosugi, M., Endoh, I., Kusama, Y., Atarashi, H., & Shimizu, W. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.31526 · Cited by 146
Primary graft dysfunction after heart transplantation: a thorn amongst the roses
Singh, S. S. A., Dalzell, J. R., Berry, C., & Al‐Attar, N. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09794-1 · Cited by 154
“TNF-α has been implicated in the pathogenesis of numerous inflammatory conditions including arthritis [137], asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS) [138], myocarditis [139] and congestive heart failure [140].”
Background
Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCAAT/enhancer binding protein (C/EBP).
Ron, D., Brasier, A. R., McGehee, R. E., & Habener, J. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115566 · Cited by 144
Sex-based cardiac physiology
Luczak, E. D., & Leinwand, L. A. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163156 · Cited by 143
Endothelial cytosolic proteins bind to the 3′ untranslated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis factor alpha
Alonso, J., Sánchez de Miguel, L., Montón, M., Casado, S., & López-Farré, A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.5719 · Cited by 146
“endothelial eNOS may contribute to the development of vascular disorders such as atherosclerosis or myocardial ischemia, in which increased production of TNF-a and impaired endothelium-dependent vasodilator response have been reported (3, 14, 19, 20).”
Background
Nutritional Alterations and the Effect of Fish Oil Supplementation in Dogs with Heart Failure
Freeman, L. M., Rush, J. E., Kehayias, J. J., Ross, J. N., Meydani, S. N., Brown, D. J., Dolnikowski, G. G., Marmor, B., White, M. E., Dinarello, C. A., et al. (1998) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1998.tb02148.x · Cited by 146
Neutrophil superoxide anion–generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy
Ellis, G. R., Anderson, R. A., Lang, D., Blackman, D. J., Morris, R. H. K., Morris‐Thurgood, J., McDowell, I., Jackson, S. K., LEWIS, M. J., & Frenneaux, M. P. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00916-5 · Cited by 144
“Tumor necrosis factor-a, which is elevated in CHF (30), also appears to modulate the activity of the NADPH/ NADH oxidase system (31).”
Background
Magnetic Resonance Imaging and Invasive Evaluation of Development of Heart Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α
Franco, F., Thomas, G. D., Giroir, B. P., Bryant, D. D., Bullock, M., Chwialkowski, M. P., Victor, R. G., & Peshock, R. M. (1999) · Circulation · doi:10.1161/01.cir.99.3.448 · Cited by 145
“In the present study, we asked (1) Does MRI provide a”
BackgroundResult
Tumor Necrosis Factor-α Confers Resistance to Hypoxic Injury in the Adult Mammalian Cardiac Myocyte
Nakano, M., Knowlton, A. A., Dibbs, Z. I., & Mann, D. L. (1998) · Circulation · doi:10.1161/01.cir.97.14.1392 · Cited by 144
Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure
Rauchhaus, M., Koloczek, V., Volk, H., Kemp, M., Niebauer, J., Francis, D. P., Coats, A. J. S., & Anker, S. D. (2000) · International Journal of Cardiology · doi:10.1016/s0167-5273(00)00224-2 · Cited by 144
Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol
Rössig, L., Haendeler, J., Mallat, Z., Hugel, B., Freyssinet, J., Tedgui, A., Dimmeler, S., & Zeiher, A. M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01002-0 · Cited by 145
New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress
Givertz, M. M., & Colucci, W. S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)90017-4 · Cited by 143
Assessing the safety of biologic agents in patients with rheumatoid arthritis
Rubbert‐Roth, A. (2012) · Rheumatology · doi:10.1093/rheumatology/kes114 · Cited by 139
Exercise Improves Flow-Mediated Vasodilatation of Skeletal Muscle Arteries in Rats With Chronic Heart Failure
Varin, R., Mulder, P. G. H., Richard, V. J., Tamion, F., Devaux, C., Henry, J., Lallemand, F., Lerebours, G., & Thuillez, C. (1999) · Circulation · doi:10.1161/01.cir.99.22.2951 · Cited by 141
A role for cardiac mast cells in the pathogenesis of hypertensive heart disease
Shiota, N., Rys??, J., Kovanen, P. T., Ruskoaho, H. J., Kokkonen, J. O., & Lindstedt, K. A. (2003) · Journal of Hypertension · doi:10.1097/00004872-200310000-00022 · Cited by 141
Cardiac-Specific Overexpression of Inducible Nitric Oxide Synthase Does Not Result in Severe Cardiac Dysfunction
Heger, J., Gödecke, A., Flögel, U., Merx, M. W., Molojavyi, A., Kühn‐Velten, W. N., & Schrader, J. (2002) · Circulation Research · doi:10.1161/hh0102.102757 · Cited by 141
Decreased hematopoiesis in bone marrow of mice with congestive heart failure
Iversen, P. O., Woldbæk, P. R., Tønnessen, T., & Christensen, G. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2002.282.1.r166 · Cited by 141
“The various inhibitory effects of TNF- are pronounced in the cachectic state frequently noted among patients with heart failure (14).”
Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure
Lenk, K., Erbs, S., Höllriegel, R., Beck, E. B., Linke, A. H.-P., Gielen, S., Winkler, S. M., Sandri, M., Hambrecht, R., Schuler, G. C., et al. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711402735 · Cited by 140
PPARδ modulates lipopolysaccharide-induced TNFα inflammation signaling in cultured cardiomyocytes
Ding, G., Cheng, L., Qin, Q., Frontin, S., & Yang, Q. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.03.422 · Cited by 141
Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support
Kormos, R. L., Gasior, T. A., Kawai, A., Pham, S. M., Murali, S., Hattler, B. G. J., & Griffith, B. P. (1996) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70337-9 · Cited by 139
Is insulin an antiinflammatory molecule?
Das, U. N. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00518-4 · Cited by 140
Autonomic imbalance and immune activation in chronic heart failure — Pathophysiological links
Jankowska, E. A., Ponikowski, P. P., Piepoli, M. F., Banasiak, W., Anker, S. D., & Poole-Wilson, P. A. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.013 · Cited by 138
“Additionally, activation of the immune response promotes the development of endothelial dysfunction, general body wasting, skeletal muscle apoptosis, and anorexia in CHF [23,24,35,36].”
Angiotensin II Induces Tumor Necrosis Factor Biosynthesis in the Adult Mammalian Heart Through a Protein Kinase C–Dependent Pathway
Kalra, D. K., Sivasubramanian, N., & Mann, D. L. (2002) · Circulation · doi:10.1161/01.cir.0000015603.84788.47 · Cited by 138
Tumor necrosis factor-α in cardiovascular biology and the potential role for anti-tumor necrosis factor-α therapy in heart disease
Sack, M. N. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00176-6 · Cited by 140
Tumor Necrosis Factor-α Induces a Biphasic Effect on Myocardial Contractility in Conscious Dogs
Murray, D. R. P., & Freeman, G. L. (1996) · Circulation Research · doi:10.1161/01.res.78.1.154 · Cited by 137
Is Tumor Necrosis Factor an Important Neurohormonal Mechanism in Chronic Heart Failure?
Packer, M. (1995) · Circulation · doi:10.1161/01.cir.92.6.1379 · Cited by 135
Self-citation
A Glossary of Circulating Cytokines in Chronic Heart Failure
Adamopoulos, S. N., Parissis, J., & Kremastinos, D. T. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00156-8 · Cited by 134
Elevated Concentrations of CCL2 and Tumor Necrosis Factor–α in Chagasic Cardiomyopathy
Talvani, A., Rocha, M. O. D. C., Barcelos, L. S., Gomes, Y. M., Ribeiro, A. L. P., & Teixeira, M. M. (2004) · Clinical Infectious Diseases · doi:10.1086/381892 · Cited by 136
“Several studies have now clearly demonstrated the remarkable correlation between the concentration of TNF-a in plasma and the degree of heart failure [6, 25, 26].”
Background
IL-12 Protects against Coxsackievirus B3-Induced Myocarditis by Increasing IFN-γ and Macrophage and Neutrophil Populations in the Heart
Fairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Steele, R. A., Gatewood, S. J. L., & Rose, N. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.261 · Cited by 133
Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation.
Brunkhorst, F., Clark, A., Forycki, Z., & Anker, S. D. (1999) · International Journal of Cardiology · doi:10.1016/s0167-5273(99)00118-7 · Cited by 141
Pathophysiological Role of Cytokines in Congestive Heart Failure
Blum, A., & Miller, H. I. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.15 · Cited by 135
Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients
Gonçalves, S., Pecoits‐Filho, R., Perreto, S., Barberato, S. H., Stinghen, A. E. M., Lima, E. G. A., Fuerbringer, R., Sauthier, S., & RIELLA, M. C. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl273 · Cited by 135
“Endotoxin circulation potentially leads to an increased production of pro-inflammatory cytokines [30].”
Background
Risk factors for heart failure
Kenchaiah, S., Narula, J., & Vasan, R. S. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.016 · Cited by 136
“Elevated levels of TNF-a have been observed in patients with chronic HF [195–197].”
Background
Congestive Heart Failure: Fifty Years of Progress
D, E. B. M., & Bristow, M. R. (2000) · Circulation · doi:10.1161/circ.102.suppl_4.iv-14 · Cited by 134
Prognostic value of simple frailty and malnutrition screening tools in patients with acute heart failure due to left ventricular systolic dysfunction
Sze, S., Zhang, J., Pellicori, P., Morgan, D., Hoye, A., & Clark, A. L. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1082-5 · Cited by 134
“Impaired cardiac pump function and subsequent hypoperfusion of peripheral tissues lead to cellular damage and activation of cytokines (tumor necrosis factor-α and nuclear factor-KB) [29] as well as the renin–angiotensin–aldosterone and adrenergic nervous system.”
Background
l -Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure
Vescovo, G., Ravara, B., Gobbo, V., Sandri, M., Angelini, A., Barbera, M. D., Donà, M., Peluso, G., Calvani, M., Mosconi, L., et al. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00046.2002 · Cited by 133
“Myocyte death is triggered by cytokine activation, which is almost always present in heart failure as a sign of a chronic inflammatory state (13, 14).”
Background
Transgenic Overexpression of Locally Acting Insulin-Like Growth Factor-1 Inhibits Ubiquitin-Mediated Muscle Atrophy in Chronic Left-Ventricular Dysfunction
Schulze, P. C., Fang, J. S., Kassik, K. A., Gannon, J., Cupesi, M., MacGillivray, C., Lee, R. T., & Rosenthal, N. A. (2005) · Circulation Research · doi:10.1161/01.res.0000179580.72375.c2 · Cited by 136
Knockdown of TNF-α by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction
Somasuntharam, I., Yehl, K. M., Carroll, S. L., Maxwell, J. T., Martinez, M. D., Che, P.-L., Brown, M. E., Salaita, K. S., & Davis, M. E. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.022 · Cited by 136
TNF-?, rheumatoid arthritis, and heart failure: a rheumatological dilemma
Sarzi‐Puttini, P., Atzeni, F., Shoenfeld, Y., & Ferraccioli, G. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.09.004 · Cited by 132
Anemia in Patients With Heart Failure: Prevalence and Prognostic Role in a Controlled Trial and in Clinical Practice
Maggioni, A. P., Opasich, C., Anand, I. S., Barlera, S., Carbonieri, E., Gonzini, L., Tavazzi, L., Latini, R., & Cohn, J. N. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.05.004 · Cited by 131
Calcium-dependent arrhythmias in transgenic mice with heart failure
London, B., Baker, L. C., Lee, J. S., Shusterman, V., Choi, B., Kubota, T., McTiernan, C. F., Feldman, A. M., & Salama, G. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00431.2002 · Cited by 131
“Inflammatory cytokines, including TNF- , are increased in the serum and hearts of patients with CHF and may contribute to the pathophysiology of the disease (22, 37, 38).”
Background
Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting
Breitbart, A., Auger‐Messier, M., Molkentin, J. D., & Heineke, J. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00200.2011 · Cited by 139
“The serum concentrations of proinflammatory cytokines like TNF- , IL-6, and IL-1 are known to be high in patients with cardiac cachexia (8, 45, 82).”
Background
Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure
Yue, P., Massie, B. M., Simpson, P. C., & Long, C. S. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.275.1.h250 · Cited by 131
Prognostic value of malnutrition assessed by Controlling Nutritional Status score for long-term mortality in patients with acute heart failure
Iwakami, N., Nagai, T., Furukawa, T. A., Sugano, Y., Honda, S., Okada, A., Asaumi, Y., Aiba, T., Noguchi, T., KUSANO, K. F., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.12.064 · Cited by 131
“reactions [29-36] These adverse reactions affect immunity, insulin resistance [37, 38] and anabolic-catabolic balance [39] leading to impaired protein and lipid metabolism, which finally results in malnutrition and cachexia.”
Background
Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6
Geppert, A., Steiner, A., Zorn, G., Delle‐Karth, G., Koreny, M., Haumer, M., Siostrzonek, P., Huber, K., & Heinz, G. (2002) · Critical Care Medicine · doi:10.1097/00003246-200209000-00007 · Cited by 129
“In fact, IL-6 elevations are also seen in patients with burn injuries (7), trauma (8), pancreatitis (9), heart failure (10, 11), and acute myocardial infarction (AMI) (12, 13).”
Background
Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure
Kubota, T., Miyagishima, M., Alvarez, R., Kormos, R. L., Rosenblum, W. D., Demetris, A. J., Semigran, M. J., Dec, G. W., Holubkov, R., McTiernan, C. F., et al. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00173-x · Cited by 130
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations
Klein, L., O’Connor, C. M., Gattis, W. A., Zampino, M., Luca, L. D., Vitarelli, A., Fedele, F., & Gheorghiade, M. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03336-2 · Cited by 130
Beneficial Effects of Pentoxifylline in Patients With Idiopathic Dilated Cardiomyopathy Treated With Angiotensin-Converting Enzyme Inhibitors and Carvedilol
Skudicky, D., Bergemann, A., Sliwa, K. S., Candy, G. P., & Sareli, P. (2001) · Circulation · doi:10.1161/01.cir.103.8.1083 · Cited by 127
Obesity and survival in patients with heart failure and preserved systolic function: A U-shaped relationship
Kapoor, J. R., & Heidenreich, P. A. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.10.026 · Cited by 130
“001 Calcium antagonist, n (%) 14 (29) 96 (40) 146 (37) 107 (42) 55 (37) 30 (41) 20 (37) .”
Acute Renal Failure: Much More Than a Kidney Disease
Kelly, K. J. (2006) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2005.09.003 · Cited by 130
Cardiac cachexia: hic et nunc
Loncar, G., Springer, J., Anker, M. S., Doehner, W., & Lainščak, M. (2016) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12118 · Cited by 130
“Increased circulating levels of pro-inflammatory cytokines characterized HF, namely tumor necrosis factor alpha (TNF-α), interleukin-1, and interleukin-6 [14–17].”
Background
Strong Association Between Volume Status and Nutritional Status in Peritoneal Dialysis Patients
Cheng, L.-T., Tang, W., & Wang, T. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.01.037 · Cited by 128
Factors contributing to the exercise limitation of heart failure
Wilson, J. R., & MANCINI, D. M. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90469-h · Cited by 128
Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives
Kjær, A., & Hesse, B. (2001) · Clinical Physiology · doi:10.1046/j.1365-2281.2001.00371.x · Cited by 129
“TNF-a is increased in CHF and seems to re¯ect the severity of the disease (Levine et al., 1990; Testa et al., 1996; Torre et al., 1996).”
Background
Macrophages and Cardiovascular Health
Frodermann, V., & Nahrendorf, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00068.2017 · Cited by 128
Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality
Goldstein, D. J., Seldomridge, J. A., Chen, J. M., Catanese, K. A., DeRosa, C. M., Weinberg, A. D., Smith, C. R., Rose, E. A., Levin, H. R., & Öz, M. C. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00086-z · Cited by 127
The roles of HIF-1α signaling in cardiovascular diseases
Sato, T., & Takeda, N. (2022) · Journal of Cardiology · doi:10.1016/j.jjcc.2022.09.002 · Cited by 135
Tumor Necrosis Factor Receptor Levels Are Associated With Carotid Atherosclerosis
Elkind, M. S. V., Cheng, J., Boden-Albala, B. M., Rundek, T., Thomas, J. A., Chen, H., Rabbani, L. E., & Sacco, R. L. (2002) · Stroke · doi:10.1161/hs0102.100531 · Cited by 126
Loss of bone mineral in patients with cachexia due to chronic heart failure
Anker, S. D., Clark, A. L., Teixeira, M. M., Hellewell, P. G., & Coats, A. J. S. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00927-8 · Cited by 125
Exercise Intolerance in Chronic Heart Failure
Okita, K., Kinugawa, S., & Tsutsui, H. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-1235 · Cited by 124
IL-6 levels in acute and post myocardial infarction: their relation to CRP levels, infarction size, left ventricular systolic function, and heart failure
Gabriel, A. S., Martinsson, A., Wretlind, B., & Ahnve, S. (2004) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2004.07.013 · Cited by 124
“Cytokine activity has also been implicated in the mediation of the depression of myocardial function as seen in congestive heart failure (HF) [4] and sepsis [5].”
Background
Tumor Necrosis Factor-α–Converting Enzyme and Tumor Necrosis Factor-α in Human Dilated Cardiomyopathy
Satoh, M., Nakamura, M., Saitoh, H., Satoh, H., Maesawa, C., Segawa, I., Tashiro, A., & Hiramori, K. (1999) · Circulation · doi:10.1161/01.cir.99.25.3260 · Cited by 124
The Effect of TNF Inhibitors on Cardiovascular Events in Psoriasis and Psoriatic Arthritis: an Updated Meta-Analysis
Yang, Z.-S., Lin, N.-N., Li, L., & Li, Y. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8560-9 · Cited by 123
Tumour necrosis factor-? and the failing heart
von Haehling, S., Jankowska, E. A., & Anker, S. D. (2004) · Basic Research in Cardiology · doi:10.1007/s00395-003-0433-8 · Cited by 121
Prognostic value of serum cytokines in patients with congestive heart failure
Orús, J., Roig, E. S., Pérez‐Villa, F., Paré, C., Azqueta, M., Filella, X., Heras, M., & Sanz, G. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00083-8 · Cited by 123
Resting Energy Expenditure and Subsequent Mortality Risk in Peritoneal Dialysis Patients
Wang, A. Y.-M., Sea, M. M.-M., Tang, N. L. S., Sanderson, J. E., Lui, S., Li, P. K., & Woo, J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000144206.29951.b2 · Cited by 121
TNFα receptor expression in rat cardiac myocytes: TNFα inhibition of L‐type Ca2+ current and Ca2+ transients
Krown, K. A., Yasui, K., Brooker, M. J., Dubin, A. E., Nguyen, C., Harris, G. L., McDonough, P. M., Glembotski, C. C., Palade, P., & Sabbadini, R. A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01238-5 · Cited by 123

Authors: Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M.
Affiliations: City University of New York (US)
ORCID: Levine, Beth
Fillit, Howard M.
Packer, Milton
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1990-07-26
Volume: 323
Issue: 4
Pages: 236-241
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199007263230405
OpenAlex: W2324476825
Cited by: 2,582
References: 55
Citations by year: 2026: 21 · 2025: 43 · 2024: 49 · 2023: 34 · 2022: 70 · 2021: 63 · 2020: 64 · 2019: 64 · 2018: 59 · 2017: 64 · 2016: 58 · 2015: 70 · 2014: 75 · 2013: 73 · 2012: 79
FWCI: 29.44
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (7r01hl025055-11, 5r01ca041583-06, 5k04hl001229-02)
National Heart, Lung, and Blood Institute (KO4-HL-01229, R01-HL-25055)
National Cancer Institute (R01-CA41583)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
Keywords: TNF-α, chronic heart failure, cardiac cachexia, serum cytokines, plasma renin activity, serum sodium, hemoglobin, blood urea nitrogen, chronic kidney disease, cytokine clearance, advanced heart failure, weight loss, inflammation in heart failure, anemia of heart failure, hyperuricemia, hyperkalemia
MeSH terms: Adult, Aged, Aged, 80 and over, Chronic Disease, Female, Heart Failure, Hemoglobins, Humans, Male, Middle Aged, Renin, Sodium, Tumor Necrosis Factor-alpha

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks